CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

CEL SCI CORP

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$1.65−0.14 (-7.82%)

Close on Oct 19, 2026

Market cap: $19.99M
P/E (TTM): –
Dividend yield: –

CEL SCI CORP balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30	FY 2019 2019-09-30	FY 2018 2018-09-30	FY 2017 2017-09-30	FY 2016 2016-09-30	FY 2015 2015-09-30	FY 2014 2014-09-30	FY 2013 2013-09-30	FY 2012 2012-09-30	FY 2011 2011-09-30	FY 2010 2010-09-30	FY 2009 2009-09-30	FY 2008 2008-09-30
Cash & Equivalents	11	4.74	4.15	23	36	16	8.44	10	2.37	2.92	5.73	8.51	0.04	3.94	4.26	27	34	0.71
Short-Term Investments	–	–	–	0	6.15	0	–	–	–	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	11	4.74	4.15	23	42	16	8.44	10	2.37	2.92	5.73	8.51	0.04	3.94	4.26	27	34	0.71
Receivables	–	–	–	0	0.05	0.05	0.06	0.12	0.22	0.39	0.09	0.08	0.07	0.16	0.46	0	–	–
Inventory	–	1.02	2.25	2.00	2.01	0.82	0.78	0.65	0.67	1.01	1.40	1.45	1.02	1.38	1.57	1.48	–	–
Prepaid Expenses & Other	0.33	0.29	0.52	0.76	1.00	1.31	0.52	0.36	0.83	0.98	0.98	0.91	0.78	1.31	2.03	–	–	–
Total Current Assets	12	6.06	6.92	25	45	18	9.81	11	4.24	5.46	8.35	12	2.51	7.44	9.02	29	–	–
Property, Plant & Equipment	6.08	8.13	10	12	14	5.84	16	16	17	17	18	0.40	0.49	0.63	1.03	1.26	–	–
Gross Property, Plant & Equipment	18	18	18	18	18	9.52	25	25	25	25	25	3.50	3.46	3.34	–	–	–	–
Accumulated Depreciation	-12	-10	-7.94	-5.85	-4.11	-3.67	-8.95	-8.38	-7.82	-7.26	-6.78	-3.10	-2.97	-2.71	-3.03	-2.63	–	–
Buildings & Improvements	–	–	–	–	–	–	–	–	–	21	21	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	1.27	1.50	1.70	1.88	2.06	1.20	0	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.12	0.17	0.20	0.21	0.28	–	0.31	0.26	0.22	0.26	0.29	0.32	0.32	0.38	0.41	0.36	–	–
Total Assets	28	27	31	51	76	41	28	30	23	25	29	19	11	16	19	38	–	–
Accounts Payable	1.06	1.45	2.01	1.62	1.68	2.02	1.59	5.74	8.20	3.09	5.13	1.16	1.92	0.59	0.74	1.50	–	–
Accrued Expenses	0.71	0.57	1.05	0.84	0.86	0.51	0.03	0.21	0.94	0.38	0.09	0.55	0.11	0.01	0.29	0.22	–	–
Current Portion of Long-Term Debt	2.27	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Debt	2.27	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Portion of Leases	0.17	0.23	0.20	0.17	–	0.90	0.10	–	–	–	–	–	–	–	–	–	–	–
Other Current Liabilities	–	–	–	–	–	0	0.01	0.01	0.01	0.00	0.02	–	–	–	–	–	–	–
Total Current Liabilities	5.13	4.62	5.59	4.66	3.94	4.27	3.02	9.23	11	4.01	6.71	3.15	3.55	1.91	7.22	3.30	–	–
Long-Term Debt	5.68	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Long-Term Leases	1.26	1.43	1.65	1.85	2.02	1.11	0	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	1.43	1.65	1.85	2.00	2.02	1.30	1.30	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	0.13	0.13	0.13	0.13	0.13	0.13	0.15	0.03	0.04	0.02	0.01	–	–	–	–	–	–	–
Total Liabilities	12	14	17	18	19	21	22	30	26	26	33	8.79	4.14	9.04	9.55	9.95	–	–
Total Debt	7.96	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Preferred Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–
Common Stock	0.08	0.02	0.47	0.43	0.43	0.39	0.35	0.28	0.12	0.06	0.04	0.82	0.31	0.27	2.15	2.05	–	–
Additional Paid-In Capital	555	527	500	487	474	401	359	331	296	285	269	249	219	210	194	188	–	–
Retained Earnings	-539	-514	-487	-455	-418	-382	-354	-332	-300	-285	-274	-239	-212	-203	-188	-162	–	–
Shareholders' Equity	16	13	13	32	57	20	5.13	0.00	-3.34	-0.68	-4.76	11	6.70	7.03	9.08	28	8.84	11
Total Equity	16	13	13	32	57	20	5.13	0.00	-3.34	-0.68	-4.76	11	6.70	7.03	9.08	28	8.84	11
Total Liabilities & Equity	28	27	31	51	76	41	28	30	23	25	29	19	11	16	19	38	–	–
Shares Outstanding(shares)	8.02	2.13	1.58	1.45	1.44	1.29	1.17	0.93	0.40	0.21	0.15	0.11	0.04	0.04	0.03	0.03	–	–
Deposits	–	–	–	–	–	–	–	–	–	0.01	0.01	0.01	0.01	0.01	0	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -176.3%

Financial strength

Current ratio: 1.48
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 128.5%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1.82
Dividend yield: –